[GLUE] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[GLUE] Monte Rosa Therapeutics, Inc.
Announcement Date
16-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -45.42%
Quarter Report
GLUE's Result
GLUE's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
Revenue 0 0 0 0 0 -
PBT -135,014 -108,501 -73,958 -35,879 -7,740 104.26%
Tax 338 -3,883 -2,016 189 277 5.09%
NP -135,352 -104,618 -71,942 -36,068 -8,017 102.60%
Tax Rate - - - - - -
Total Cost 135,352 104,618 71,942 36,068 8,017 102.60%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 CAGR
EPS -2.63 -2.22 -1.55 -0.82 -0.18 95.42%
EPS Diluted -2.63 -2.22 -1.55 -0.82 -0.18 95.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.